Yearly Archives: 2019

Nov 18, 2019: Novartis Phase III PARAGON-HF study plays a key role for patients with diastolic heart failure with preserved ejection fraction (HFpEF). From the...

Nov 18, 2019: Dr Catherine Hogan at Cardiff University’s European Cancer Stem Cell Research Institute has been awarded the funding of £373k  by Cancer...

Nov 15, 2019: Shanghai Fosun Pharmaceutical and MimiVax LLC have entered into a China-exclusive licensing agreement for the clinical development and commercialization of SurVaxM....

Nov. 15, 2019: Amgen and the Duke Clinical Research Institute (DCRI) announced plans to initiate the Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 inhibitors (cvMOBIUS) study in order to calculate...

Nov 15, 2019: NIH researchers found that a single, subanesthetic-dose of ketamine infusion was relatively free of side effects for patients with treatment-resistant depression...

Nov 15, 2019: FDA approved Novartis's Adakveo (crizanlizumab-tmca) for the treatment to reduce the frequency of vaso-occlusive crisis in sickle cell disease...

Nov 16, 2019: PRINCETON, N.J. and Bristol-Myers Squibb-Pfizer Alliance announced the initiation of a new randomized controlled trial (GUARD-AF) for undiagnosed atrial fibrillation in elderly...

Nov 16, 2019: Bacterial infection affects millions of American adults in a year and is one of the strongest known causes of stomach cancer,...

Nov 16, 2019: USFDA approved Zydus Cadila’s Apremilast tablets for the treatment of psoriatic arthritis and moderate to severe plaque psoriasis. The US health regulator...

Nov 14, 2019: The U.S. Food and Drug Administration (FDA)  approved Shionogi’s Fetroja (cefiderocol), an antibacterial drug used for the patients of 18 years...